HeamSeq Comprehensive Plus Leukemia Panel

What is Heamseq comprehensive plus leukemia panel test?

Heamseq comprehensive plus leukemia panel test is an advanced Next-Generation Sequencing (NGS) based test designed to analyze a wide range of genetic mutations and chromosomal abnormalities associated with chronic lymphoproliferative disorders (CLPDs) and other hematologic malignancies. It covers a broad spectrum of genes implicated in both acute and chronic leukemias, as well as myelodysplastic and myeloproliferative disorders, providing an extensive molecular profile of the disease. Heamseq comprehensive plus leukemia panel test helps identify driver mutations, prognostic markers, and potential therapeutic targets, enabling clinicians to choose the most effective, personalized treatment approach.

Why consider Heamseq comprehensive plus leukemia panel test?

Heamseq comprehensive plus leukemia panel test is considered for

• To detect multiple genetic mutations in a single test for a comprehensive molecular diagnosis.
• To classify the type and subtype of leukemia or lymphoproliferative disorder
• To guide targeted therapy and precision medicine decisions.
• To determine prognostic risk and assist in treatment planning.
• To monitor disease progression or relapse in patients under treatment.

Who should get tested Heamseq comprehensive plus leukemia panel test?

Heamseq comprehensive plus leukemia panel test is generally recommended for:

• Patients with suspected or confirmed chronic lymphoproliferative disorders (CLPDs).
• Individuals diagnosed with acute or chronic leukemias, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPNs).
• Patients showing abnormal blood counts, lymphocytosis, or bone marrow abnormalities.
• Oncologists and hematologists seeking comprehensive genomic insights for personalized treatment decisions.

More Information

Other Names: Hematologic Malignancy Comprehensive NGS Panel, Leukemia & Lymphoma Molecular Panel, HeamSeq Advanced Hemato-Oncology Panel

Leukemia is a cancer of the blood and bone marrow. In simple terms, cancer is defined as the uncontrolled growth of abnormal cells. Cancer can develop anywhere in the body. In leukemia, this rapid, out-of-control growth of abnormal cells takes place in the bone marrow. These abnormal cells then spill into the bloodstream. Unlike other cancers, Leukemia generally doesn’t form into a mass (tumour) that can be seen in imaging tests, such as X-rays. Acute Leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into primitive, undifferentiated cell with abnormal longevity. These lymphoid cells or myeloid cells proliferate abnormally, replacing normal marrow tissue and hematopoietic cells.